The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review
Open accessAbstract
Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflammatory effects. While the clinical outcome in case reports and phase I-II trials seems occasionally striking, these limited results point to the need to perform controlled multicenter trials. Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“…or together with tumor necrosis factor (TNF)-α, IL-1α or IL-1β, are required to trigger the expression by MSCs of high levels of soluble factors involved in immunosuppression such as IDO, HGF, TGF-β, and NO (Aggarwal and Pittenger, 2005; Ryan et al., 2007; Krampera et al., 2006, Ren et al., 2008 ).”
Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001886 · Cited by 1,610
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622
Cited by
Human mesenchymal stem cells - current trends and future prospective
Ullah, I., Subbarao, R. B., & Rho, G. J. (2015) · Bioscience Reports · doi:10.1042/bsr20150025 · Cited by 1,337
Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., Phillips, M., & Herrmann, R. P. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.021 · Cited by 333
Regmi, S., Pathak, S., Kim, J. O., Yong, C. S., & Jeong, J.-H. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.04.002 · Cited by 314
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
Najar, M., Raicevic, G., Fayyad-Kazan, H., Bron, D., Toungouz, M., & Lagneaux, L. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.011 · Cited by 267
Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke
Vu, Q., Xie, K., Eckert, M., Zhao, W., & Cramer, S. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000278 · Cited by 235
Metadata
- Authors
- Figueroa, F. E., Carrión, F., Villanueva, S., & Khoury, M.
- Venue
- Biological Research
- Published
- 2012
- Volume
- 45
- Issue
- 3
- Pages
- 269-277
- ISSN
- 0716-9760 (ISSN-L)
- OpenAlex
- W2095977249
- Cited by
- 174
- References
- 4
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review. https://app.cochat.ai/papers/10.4067/s0716-97602012000300008
- The paper
- Figueroa, F. E., Carrión, F., Villanueva, S., & Khoury, M. (2012). Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review. Biological Research. https://doi.org/10.4067/s0716-97602012000300008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.